Akanda Corp. (AKAN)

1.72 -0.25 (-12.69%) USD  |  NASDAQ  |  Jan 14, 13:43
More

Akanda Revenue Estimates for Current Quarter

Revenue Estimates for Current Quarter Chart

View Revenue Estimates for Current Quarter for AKAN.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Revenue Estimates for Current Quarter Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Revenue Estimates for Current Quarter Range, Past 5 Years

View Revenue Estimates for Current Quarter Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Revenue Estimates for Current Quarter Benchmarks

View Revenue Estimates for Current Quarter Benchmarks
Start Trial
Alterola Biotech, Inc. --
Kiniksa Pharmaceuticals International Plc Upgrade
Aditxt, Inc. Upgrade
Iovance Biotherapeutics, Inc. Upgrade
Travere Therapeutics, Inc. Upgrade